0001209191-22-043897.txt : 20220802
0001209191-22-043897.hdr.sgml : 20220802
20220802164731
ACCESSION NUMBER: 0001209191-22-043897
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220801
FILED AS OF DATE: 20220802
DATE AS OF CHANGE: 20220802
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Mordwinkin Nicholas Michael
CENTRAL INDEX KEY: 0001937229
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38542
FILM NUMBER: 221129443
MAIL ADDRESS:
STREET 1: C/O KEZAR LIFE SCIENCES, INC.
STREET 2: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Kezar Life Sciences, Inc.
CENTRAL INDEX KEY: 0001645666
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 473366145
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-822-5600
MAIL ADDRESS:
STREET 1: 4000 SHORELINE COURT, SUITE 300
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2022-08-01
0
0001645666
Kezar Life Sciences, Inc.
KZR
0001937229
Mordwinkin Nicholas Michael
C/O KEZAR LIFE SCIENCES, INC.
4000 SHORELINE COURT, SUITE 300
SOUTH SAN FRANCISCO
CA
94080
0
1
0
0
Chief Business Officer
Employee Stock Option (right to buy)
9.35
2022-08-01
4
A
0
200000
0.00
A
2032-07-31
Common Stock
200000
200000
D
Twenty five percent (25%) of the shares will vest on July 11, 2023, and 1/48th of the total shares will vest each month thereafter, subject to Reporting Person continuing to provide service through such date.
/s/ Marc Belsky, Attorney-in-Fact
2022-08-02